Molecular docking, synthesis and biological evaluation of Vascular Endothelial Growth Factor (VEGF) B based peptide as antiangiogenic agent targeting the second domain of the Vascular Endothelial Growth Factor Receptor 1 (VEGFR1D2) for anticancer application

Sadremomtaz, A., Ali, A. M., Jouyandeh, F., Balalaie, S., Navari, R., Broussy, S., Mansouri, K., Groves, M. R. & Asghari, S. M., 5-Jun-2020, In : Signal transduction and targeted therapy. 5, 1, 4 p., 76.

Research output: Contribution to journalArticleAcademicpeer-review

  • Afsaneh Sadremomtaz
  • Ameena M Ali
  • Foroozan Jouyandeh
  • Saeed Balalaie
  • Razieh Navari
  • Sylvain Broussy
  • Kamran Mansouri
  • Matthew R Groves
  • S Mohsen Asghari
Original languageEnglish
Article number76
Number of pages4
JournalSignal transduction and targeted therapy
Issue number1
Publication statusPublished - 5-Jun-2020

Download statistics

No data available

ID: 126795905